Document And Entity Information - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2018
Feb. 26, 2019
Jun. 30, 2018
Document Information [Line Items]      
Entity Registrant Name Zomedica Pharmaceuticals Corp.    
Entity Central Index Key 0001684144    
Trading Symbol zom    
Current Fiscal Year End Date --12-31    
Entity Filer Category Accelerated Filer    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Well-known Seasoned Issuer No    
Entity Emerging Growth Company true    
Entity Ex Transition Period true    
Entity Small Business true    
Entity Common Stock, Shares Outstanding (in shares)   101,121,923  
Entity Public Float     $ 95
Entity Shell Company false    
Document Type 10-K/A    
Document Period End Date Dec. 31, 2018    
Document Fiscal Year Focus 2018    
Document Fiscal Period Focus FY    
Amendment Flag true    
Amendment Description This Amendment No. 1 on Form 10-K/A (this “Form 10-K/A”) amends and restates in its entirety the Annual Report on Form 10-K for the year ended December 31, 2018 (the “Original Form 10-K”) of Zomedica Pharmaceuticals Corp. (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) on February 26, 2019 to include material inadvertently omitted from the Original Form 10-K. As required by Rule 12b-15 of the Securities Exchange Act of 1934, as amended, this Form 10-K/A contains new certifications by the Company’s principal executive officer and principal financial officer, which are being filed as exhibits to this Form 10-K/A. Because this Form 10-K/A includes financial statements, the Company is also including certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.